Walgreen Company Fourth Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Walgreen Company (NYSE:WAG) will unveil its latest earnings on Tuesday, September 27, 2011. Walgreen Co. operates retail drug store and general merchandise. It is engaged in the retail sale of prescription and non-prescription drugs and general merchandise.

Walgreen Company Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 55 cents per share, a rise of 12.2% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 54 cents. Between one and three months ago, the average estimate moved up, but it has been unchanged at 55 cents during the last month. For the year, analysts are projecting net income of $2.62 per share, a rise of 23.6% from last year.

Past Earnings Performance: The company topped forecasts last quarter after being in line with estimates the quarter prior. In the third quarter, it reported profit of 65 cents per share versus a mean estimate of 62 cents. Two quarters ago, it reported net income of 80 cents per share.

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock.

Wall St. Revenue Expectations: On average, analysts predict $17.88 billion in revenue this quarter, a rise of 6% from the year ago quarter. Analysts are forecasting total revenue of $72.09 billion for the year, a rise of 6.9% from last year’s revenue of $67.42 billion.

Analyst Ratings: Analysts are bullish on this stock with 15 analysts rating it as a buy, one rating it as a sell and seven rating it as a hold.

Key Stats:

The company has now seen net income rise in three straight quarters. In the third quarter, net income rose 30.2% while it rose 10.5% in the second quarter and 18.6% in the first quarter.

Revenue has risen the past four quarters. Revenue increased 6.8% to $18.37 billion in third quarter. The figure rose 8.9% in the second quarter from the year earlier, climbed 6% in the first quarter from the year-ago quarter and 7.4% in the fourth quarter of the last fiscal year.

Competitors to Watch: drugstore.com, inc. (NASDAQ:DSCM), Graymark Healthcare Inc (NASDAQ:GRMH), CVS Caremark Corporation (NYSE:CVS), Rite Aid Corporation (NYSE:RAD), PetMed Express, Inc. (NASDAQ:PETS), China Nepstar Chain Drugstore Ltd. (NYSE:NPD), GNC Acquisition Hldgs. Inc (GNC), PharMerica Corporation (NYSE:PMC), BioScrip Inc. (NASDAQ:BIOS), and Medco Health Solutions Inc. (NYSE:MHS).

Stock Price Performance: During June 27, 2011 to September 21, 2011, the stock price had fallen $5.10 (-12.3%) from $41.47 to $36.37. It saw one of its worst periods between May 27, 2011 and June 7, 2011 when shares fell for seven-straight days, falling 1.8% (-78 cents) over that span. The stock price saw one of its best stretches over the last year between May 6, 2011 and May 16, 2011 when shares rose for seven-straight days, rising 6.6% (+$2.75) over that span. Shares are down $2.04 (-5.3%) year to date.

(Source: Xignite Financials)

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock.

 

More from The Cheat Sheet